Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Theravance Biopharma Company Profile (NASDAQ:TBPH)

Consensus Ratings for Theravance Biopharma (NASDAQ:TBPH) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $27.50 (105.68% upside)

Analysts' Ratings History for Theravance Biopharma (NASDAQ:TBPH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/2/2014Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
8/14/2014Robert W. BairdDowngradeNeutral -> Underperform$21.00ViewTweet This Rating  Share This Rating on StockTwits
6/6/2014Bank of AmericaInitiated CoverageBuy$34.00ViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Robert W. BairdInitiated CoverageNeutral$21.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/19/2012 forward)